Harvard, MIT Revive CRISPR Gene Editing Patent At EPO
A European appeals board has revived a CRISPR gene editing patent belonging to Harvard and MIT, ruling in a decision released Thursday that they can pin the priority date for their...To view the full article, register now.
Already a subscriber? Click here to view full article